Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.


CSE:AGN - Post by User

Post by BehStreet on Jul 10, 2020 9:44am
173 Views
Post# 31250658

Good morning fellow longs (and trash posters)

Good morning fellow longs (and trash posters)It's been a while since my last post as I needed a break from the nonsense. One observation as of late - Lovhouses is gone, and ironically, all the stupid posters that follow him are gone as well (interesting)..

Let's get to the subject at hand, Algernon.

Well, the technicals sure have changed for the better. AGN has made a solid bottom at .18 cents after a selloff of cheap warrents that came free trading. Shorters love shorting when that happens, and savvy investors who recognize this see it as a great buying opportunity. Hope some of you where able to capitalize sub .20 cents! We are now on the verge of closing a great trading week, resulting in a break of the downtrend. Any of you chartist analyzing the weekly or monthly timeframe chart of the past year to date might notice something very bullish forming as well (hint-it's an inverse classical pattern).

We recieved great news this week that Algernon has started screening patients for their IPF/Chronic cough phase 2 trial, right after their competitor Bellus flunked it's chronic cough trail (clap, clap!) I suspect we'll recieve news of "first patient dosed" in that trial this month. Now that will be a mile stone for the company as it has never dosed a human in a clinical trial (should be big news indeed). This study also de-risk's the stock some as we will now be testing Ifenprodil on 2 different ailments (Covid19 and IPF).

On the Covid front, the company said recruitment for their 2b/3 trial should start before the end of July 2020, so expect some news within the next 20 days (hopefully).

As for these outlandish price predictions, ie "3 dollars by the end of July/August", well, any sane person of average intelligence would see that for what it is - Scary Stuff!

With the information provided to us from the company, along with the chart and pending news, a more resonable price prediction for the end of July would be - The hell if I know! (let's for fun say north of .50 cents *if* the company is punctual on upcoming news)

As always, JMO. 

GL Longs

BehStreet


<< Previous
Bullboard Posts
Next >>